| Literature DB >> 30678177 |
Angela Tartaglia1, Marcello Locatelli2, Abuzar Kabir3, Kenneth G Furton4, Daniela Macerola5, Elena Sperandio6, Silvia Piccolantonio7, Halil I Ulusoy8, Fabio Maroni9, Pantaleone Bruni10, Fausto Croce11, Victoria F Samanidou12.
Abstract
This paper reports the performance comparison between the exhaustive and equilibrium extraction using classical Avantor C18 solid phase extraction (SPE) sorbent, hydrophilic-lipophilic balance (HLB) SPE sorbent, Sep-Pak C18 SPE sorbent, novel sol-gel Carbowax 20M (sol-gel CW 20M) SPE sorbent, and sol-gel CW 20M coated fabric phase sorptive extraction (FPSE) media for the simultaneous extraction and analysis of three inflammatory bowel disease (IBD) drugs that possess logP values (polarity) ranging from 1.66 for cortisone, 2.30 for ciprofloxacin, and 2.92 for sulfasalazine. Both the commercial SPE phases and in-house synthesized sol-gel CW 20M SPE phases were loaded in SPE cartridges and the extractions were carried out under an exhaustive extraction mode. FPSE was carried out under an equilibrium extraction mode. The drug compounds were resolved using a Luna C18 column (250 mm × 4.6 mm; 5 m particle size) in gradient elution mode within 20 min and the method was validated in compliance with international guidelines for the bioanalytical method validation. Novel in-house synthesized and loaded sol-gel CW 20M SPE sorbent cartridges were characterized in terms of their extraction capability, breakthrough volume, retention volume, hold-up volume, number of the theoretical plate, and the retention factor.Entities:
Keywords: FPSE; HPLC-PDA; IBD; extraction; in-house loaded SPE; method validation
Mesh:
Substances:
Year: 2019 PMID: 30678177 PMCID: PMC6385024 DOI: 10.3390/molecules24030382
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Molecular structures and other pertinent physiochemical properties of selected inflammatory bowel disease (IBD) drugs and the internal standard.
| Drug Name | CAS No. | Molecular Weight (g/mole) | Molecular Structure | LogP | pKa |
|---|---|---|---|---|---|
| Cortisone | 53-06-5 | 360.44 |
| 1.66 | 12.6 |
| Methyl- | 99-76-3 | 152.15 |
| 1.96 | 8.4 |
| Ciprofloxacin | 85721-33-1 | 331.34 |
| 2.30 | 5.76 |
| Sulfasalazine | 599-79-1 | 398.39 |
| 2.92 | 3.3 |
Figure 1Comparison of breakthrough curves determined for the analytes on the different solid phase extraction (SPE) sorbents and at 10 μg/mL (left) and 50 μg/mL (right).
Parameters determined for the analytes on different sorbents in frontal analysis at the concentration of 10 µg/mL.
| Sorbent | Analyte | Breakthrough Volume (mL) | Retention Volume (mL) | Hold-Up Volume (mL) | Retention Factor ( | Number of Theoretical Plates ( |
|---|---|---|---|---|---|---|
| Avantor C18 | Ciprofloxacin | >50 | - | - | - | - |
| Sulfasalazine | >50 | - | - | - | - | |
| Methyl- | 11.3 | 9.9 | 11.9 | 0.20 | 2000 | |
| Cortisone | >50 | - | - | - | - | |
| Sep-Pac Vac C18 | Ciprofloxacin | 23.6 | 16.4 | 30.6 | 0.87 | 16 |
| Sulfasalazine | >50 | - | - | - | - | |
| Methyl- | 52.8 | 37.3 | 66.8 | 0.79 | 18 | |
| Cortisone | >50 | - | - | - | - | |
| Oasis HLB | Ciprofloxacin | 27.6 | 25.9 | 28.8 | 0.11 | 845 |
| Sulfasalazine | >50 | - | - | - | - | |
| Methyl- | >50 | - | - | - | - | |
| Cortisone | >50 | - | - | - | - | |
| CW 20M | Ciprofloxacin | 5.26 | 2.2 | 8.7 | 2.95 | 1 |
| Sulfasalazine | >50 | - | - | - | - | |
| Methyl- | 4.4 | 2.9 | 4.9 | 0.66 | 13 | |
| Cortisone | 6.5 | 4.5 | 7.9 | 0.75 | 17 |
Parameters determined for the analytes on different sorbents in frontal analysis at the concentration of 50 µg/mL.
| Sorbent | Analyte | Breakthrough Volume (mL) | Retention Volume (mL) | Hold-Up Volume (mL) | Retention Factor ( | Number of Theoretical Plates ( |
|---|---|---|---|---|---|---|
| Avantor C18 | Ciprofloxacin | 15.1 | 8.8 | 32.2 | 2.68 | 5 |
| Sulfasalazine | 29.7 | 17.4 | 46.5 | 1.67 | 5 | |
| Methyl- | 6.7 | 3.7 | 14.3 | 2.91 | 3 | |
| Cortisone | 25.7 | 14.2 | 49.6 | 2.48 | 4 | |
| Sep-Pac Vac C18 | Ciprofloxacin | 5.4 | 3.6 | 7.2 | 0.99 | 12 |
| Sulfasalazine | >20 | - | - | - | - | |
| Methyl- | 21.4 | 14.7 | 27.4 | 0.87 | 15 | |
| Cortisone | >20 | - | - | - | - | |
| Oasis HLB | Ciprofloxacin | 13.9 | 8.8 | 20.7 | 1.34 | 8 |
| Sulfasalazine | >20 | - | - | - | - | |
| Methyl- | >20 | - | - | - | - | |
| Cortisone | >20 | - | - | - | - | |
| CW 20M | Ciprofloxacin | >20 | - | - | - | - |
| Sulfasalazine | 13.2 | 7.5 | 22.7 | 2.02 | 4 | |
| Methyl- | >20 | - | - | - | - | |
| Cortisone | >20 | - | - | - | - |
Figure 2FTIR spectrum for the CW 20M stationary phase.
Figure 3TGA analysis for the CW 20M stationary phase.
Enrichment factors (%) observed at concentrations of 0.8, 2.5, and 8 µg/mL of water standard solutions. The enrichment factors were calculated as the percentage of peak area enhancement (after extraction) with respect to the area of reference standard solutions.
| Analyte | QC Concentration (μg/mL) | FPSE CW 20M | SPE Format | |||
|---|---|---|---|---|---|---|
| Avantor C18 | Sep-Pac Vac C18 | Oasis HLB | CW 20M | |||
| Ciprofloxacin | 0.8 | 28.4 |
| 304 | 67 | 321 |
| 2.5 | 37.0 | 406 | 199 |
| 186 | |
| 8 | 13.6 | 200 | 188 |
| 113 | |
| Sulfasalazine | 0.8 | 248 |
| 100 | 380 | 202 |
| 2.5 | 164 | 325 | 206 |
| 217 | |
| 8 | 278 | 344 | 299 |
| 225 | |
| Methyl- | 0.8 | 190 | 204 | 78 |
| 59 |
| 2.5 | 155 | 310 | 133 |
| 113 | |
| 8 | 121 | 205 | 216 |
| 76 | |
| Cortisone | 0.8 | 136 | 80 | 123 | n.a. |
|
| 2.5 | 88 | 160 | 195 | 167 |
| |
| 8 | 128 | 203 | 240 |
| 161 | |
n.a. not available, the analyte is not detected during the analysis.
Physical characteristics of SPE sorbent phases.
| Sorbent | Sorbent Mass (mg) | Surface Area (m2/g) | Pore Diameter (Ǻ) | Pore Volume (cm3/g) | Particle Size (µm) |
|---|---|---|---|---|---|
| Oasis HLB | 30 | 800 | 80 | 1–3 | 30 |
| Sep-Pac Vac C18 | 30 | 325 | 125 | - | 55–105 |
| Avantor C18 | 30 * | 320–350 | 60 | - | 40 |
| Carbowax 20M | 30 | 990 | 71 | 1.8 | 40 |
* Commercially available in the size of 1 mL/100 mg sorbent phase; to compare cartridges with the same amount of sorbent phase, we have emptied and reconstituted them with 30 mg of their sorbent phase.